SPARC promotes the proliferation and metastasis of oral squamous cell carcinoma by PI3K/AKT/PDGFB/PDGFRβ axis
- PMID: 30706473
- DOI: 10.1002/jcp.28205
SPARC promotes the proliferation and metastasis of oral squamous cell carcinoma by PI3K/AKT/PDGFB/PDGFRβ axis
Abstract
Oral squamous cell carcinoma (OSCC) is a highly lethal cancer in the world, and the prognosis of OSCC is poor with a 60% 5-year survival rate in recent decades. Here, we introduced a novel secretory and acid glycoprotein with cysteine rich (secreted protein acidic and rich in cysteine, SPARC), which is correlated with the worst pattern of invasion (WPOI) and prognosis of OSCC. SPARC expression levels were measured in OSCC tissues and normal tissues using quantitative polymerase chain reaction and immunohistochemistry. The influence of SPARC on cell proliferation was examined by cell counting kit-8, colony formation, and Edu tests. Then, the effect of SPARC on the metastasis of OSCC cells was detected by wound healing and transwell migration assays. Next, the biologic characteristics of SPARC shared by STRING were analyzed. Furthermore, the underlying mechanisms were confirmed by western blot analysis. SPARC revealed higher expression in OSCC tissues than nontumor tissues. Higher SPARC expression was correlated with poorer tumor differentiation, poorer WPOI pattern, and significantly and shorter overall survival. Knockdown SPARC significantly restrained OSCC cell growth, migration, and invasion. In addition, bioinformatics analysis found SPARC had a coexpression network with the platelet-derived growth factor-B (PDGFB) and PI3K/AKT signaling pathways with minimal false discovery rate. Furthermore, SPARC promotes OSCC cells metastasis by regulating the expressions of PDGFB, PDGFRβ, p-PDGFRβ , and the PI3K/AKT pathway. Higher SPARC expression was positively correlated with poor WPOI and differentiation in OSCC. SPARC activates the PI3K/AKT/PDGFB/PDGFRβ axis to promote proliferation and metastasis by OSCC cell lines. Therefore, SPARC may be a potential therapeutic target for patients with OSCC.
Keywords: SPARC; WPOI; migration and invasion; oral squamous cell carcinoma.
© 2019 Wiley Periodicals, Inc.
References
REFERENCES
-
- Alachkar, H., Santhanam, R., Maharry, K., Metzeler, K. H., Huang, X., Kohlschmidt, J., … Marcucci, G. (2014). SPARC promotes leukemic cell growth and predicts acute myeloid leukemia outcome. The Journal of Clinical Investigation, 124(4), 1512-1524.
-
- Alam, R., Schultz, C. R., Golembieski, W. A., Poisson, L. M., & Rempel, S. A. (2013). PTEN suppresses SPARC-induced pMAPKAPK2 and inhibits SPARC-induced Ser78 HSP27 phosphorylation in glioma. Neuro-Oncology, 15(4), 451-461.
-
- Almangush, A., Bello, I. O., Keski-Säntti, H., Mäkinen, L. K., Kauppila, J. H., Pukkila, M., … Salo, T. (2014). Depth of invasion, tumor budding, and worst pattern of invasion: Prognostic indicators in early-stage oral tongue cancer. Head and Neck, 36(6), 811-818.
-
- Almangush, A., Bello, I. O., Coletta, R. D., Mäkitie, A. A., Mäkinen, L. K., Kauppila, J. H., … Salo, T. (2015). For early-stage oral tongue cancer, depth of invasion and worst pattern of invasion are the strongest pathological predictors for locoregional recurrence and mortality. Virchows Archiv, 467(1), 39-46.
-
- Andrae, J., Gallini, R., & Betsholtz, C. (2008). Role of platelet-derived growth factors in physiology and medicine. Genes and Development, 22(10), 1276-1312.
Grants and funding
- 81702680/National Natural Science Foundation of China
- 81772880/National Natural Science Foundation of China
- ZKX18035/Nanjing Medical Science and Technique Development Foundation
- YKK17138/Nanjing Medical Science and Technique Development Foundation
- YKK16164/Nanjing Medical Science and Technique Development Foundation
LinkOut - more resources
Full Text Sources
Miscellaneous
